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Managing controversy through consultation:
a qualitative study of communication and
trust around MMR vaccination decisions
Robert McMurray, Francine M Cheater, Anna Weighall, Carolyn Nelson, Martin Schweiger and 
Suzanne Mukherjee
Introduction
IN the United Kingdom (UK), controversy over the safety ofthe combined measles, mumps, and rubella (MMR) vac-
cination has led to growing concern among practitioners
and parents. Despite overwhelming research evidence
against a causal link between MMR vaccination and autism
and bowel disorders,1-6 media coverage of the issue has
‘succeeded in denting parents’ confidence in childhood
immunisation’7 leading to fears of future measles, mumps,
and rubella epidemics.8
There is agreement that primary care professionals, par-
ticularly general practitioners (GPs) and health visitors,
have a central role in educating parents on the safety and
effectiveness of the MMR vaccine.6,9-15 This role is broadly
conceived in terms of communicating disease information
to parents confronted with the challenge of accessing and
interpreting medical data. Difficulties faced by parents in
these respects tend to be conceptualised in terms of a cog-
nitive deficit model of understanding and learning. From
this traditional perspective, ignorance on the part of the
public is seen (often incorrectly) as a technical problem in
need of, and amenable to, remedy.16
In seeking to prescribe such a remedy, work undertaken
by McGuire indicates that statements emphasising the 
seriousness of the diseases are most likely to influence a
vaccination decision, whereas appeals to social respons-
ibility, a child’s right to be protected, the value of preven-
tion, or reference to the actions of practitioners in relation to
their own children have little impact.17 More broadly, a
recent review of risk presentation across a range of clinical
settings acknowledges that patients often desire more infor-
mation than is provided, require two-way communication of
risk in which there is an exchange of information and 
opinion between patients and practitioners, may benefit
from the inclusion of decision aids, and need balanced
information that has not been biased by practitioner
attempts to frame information in such a way as to achieve
predetermined goals.18 Indeed, Evans et al identify issues
of practitioner bias as a particular concern among parents
considering MMR vaccination.15
Despite a growing understanding of what information
should be communicated to parents, education initiatives
have met with limited success in the face of persistent —
even disproportionate — controversy.19 Concerted effort
among practitioners locally, policy makers nationally, and
bodies such as the World Health Organisation internationally,
have failed to convince many parents of MMR vaccine safety.
The result has been a decline in uptake in the UK, with
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SUMMARY
Background: Controversy over the measles, mumps, and rubella
(MMR) vaccine has reduced uptake, raising concerns of a future
disease epidemic.
Aims: To explore parents’ accounts of decision making relating to
the MMR vaccine controversy, identifying uptake determinants and
education needs.
Design of study: Qualitative interviews analysed using the
‘framework’ approach.
Setting: Five general practices in the Leeds area, 2002–2003.
Method: Sixty-nine interviews conducted with parents of children
aged between 4 and 5 years, and 12 interviews with primary care
practitioners, managers and immunisation coordinators serving
participating sites. Participants were interviewed one-to-one in a
place of their choice.
Results: The vaccination decision is primarily a function of
parental assessments of the relative acceptability and likelihood of
possible outcomes. For most parents the evidence of science and
medicine plays little role in the decision. Although local general
practitioners and health visitors are trusted information sources,
the influence of primary care providers on the vaccination decision
is limited by concerns over consultation legitimacy, discussion
opportunity, and perceptions of financial and political partiality.
Parents and practitioners identify a need for new approaches to
support decisions and learning when faced with this and similar
healthcare controversies. These include new collaborative
approaches to information exchange designed to transform rather
than supplant existing parent knowledge as part of an ongoing
learning process.
Conclusion: The study identified new ways in which parents and
practitioners need to be supported in order to increase
understanding of medical science and secure more informed
decisions in the face of health controversy.
Keywords: health services; managed care; measles-mumps-rubella
vaccine; MMR vaccine; trust; vaccination.
immunisation rates at first dose falling from a peak at 92% in
1995, to 84% in 2001–2002, with the average at second dose
standing at 74%.20
The study reported here examines why practitioner
attempts to educate parents have met with only partial 
success. It aims to shed new light on those factors that
underpin parental perceptions of risk in relation to the MMR
controversy, with particular attention to the point of lowest
uptake, namely, second dose. Finally, it seeks to pinpoint
the primary determinants of vaccination choice, and, in a
departure from previous work, analyse findings in light of
the literature on public understanding of science, to ident-
ify the developments required to support parent–practitioner
attempts to arrive at informed decisions on health interven-
tions and risks.
Methods
The research was conducted over 16 months beginning in
January 2002. Leeds Research Ethics Committee approved
the study, which took place in five general practices.
Practices were purposely sampled to allow for diversity in
the size, location and level of deprivation in the populations
served (Table 1).
Practices sent letters to all parents of children born within
1 year, ending 31 March 1998, explaining the aims, uses and
researchers associated with the study. The letters invited
parents to contact the team by telephone or freepost should
they wish to participate in the research, and were signed by
the child’s GP. Following receipt of an expression of interest,
a time for interview at the parent’s own home or place of
work was arranged. Interviews were designed to explore
parental experience and needs in relation to information and
decision support at the point of lowest uptake, namely MMR
vaccine second dose.
Practitioner interviews were also conducted (reported
elsewhere).21 These were designed to provide contextual
data describing the process of vaccine administration within
each practice, including variations in approaches and roles.
As such, they provided an account of procedures and prac-
tice within which parental accounts could be located, and
against which comparisons could be made.
All interviews were semi-structured to the extent that the
ordering of questions could be changed to reflect the flow of
conversation while allowing new issues to be introduced. To
reduce the possibility of socially desirable response, inter-
views were conducted in parents’ homes by three non-clinical
team members. Pre-study piloting and continuous transcript
comparison were used to ensure equivalence in subject topic
coverage and questioning approach across the sample.
Full transcripts of interviews were analysed using a var-
iation of the well-established ‘framework’ approach.22 Sub-
samples of transcripts were reviewed by the authors to
identify key themes for data coding. Codes were then
defined and validated through discussion among the
research team. These were then applied to the data using
the visual qualitative data processing package QSR Nvivo.
Overarching themes and ‘one-off’ or ‘deviant’ cases were
identified in order to understand the research findings and
report them in a meaningful, yet concise, way.
Results
Sixty-nine interviews were conducted with parents, 65 of whom
were mothers. The average age of parents participating in the
study was 34 years (range = 22–44 years). The mean school
leaving age of participating parents was 17 years. Sixty-four
per cent of those interviewed were in full- or part-time paid
employment. Eighty-seven per cent were married or living with
a partner, 6% were divorced or separated, and 7% were single.
The number vaccinating at both doses was 75%, just above
the average of 74% for England (Figure 1).20
Over half of all children discussed were male (57%). Half
came from families with two children, 36% from families with
three or more children, and 12% were an only child. All chil-
dren in the non-immuniser category were boys.
There were no discernible links between immunisation
status and maternal age, educational status of parent, family
structure, number of children or birth order. Three of the key
themes to emerge from the data are presented below. These
related to decision determinants, practitioner influence, and
support needs.
Decision determinants
The primary determinant of vaccination decision across the
Original papers
British Journal of General Practice, July 2004 521
HOW THIS FITS IN
What do we know?
Continuing controversy has led to 
parental concern and confusion over the 
safety of the measles, mumps, and rubella vaccine, leading to
a decline in uptake and fear of disease epidemic. Previous
research suggests that primary care practitioners have a key
role in educating parents as to the safety and effectiveness of
the vaccine, although recent campaigns in the United Kingdom
have had limited influence.
What does this paper add?
To combat safety concerns and health scares, practitioners
must be seen as expert interpreters of risk information, capable
of linking medical data on best practice to parents’ existing
frames of reference, so as to transform understanding of
decisions and facilitate informed choice. Practitioners can only
guide parents through conflicting evidence as part of a
facilitated learning process where they are seen as a trusted
impartial source. Recovery of this position is contingent on
removing target payments, lessening restrictions on time, and
developing skills for the assessment of prior knowledge and
management of targeted information exchange.
Table 1. Practice deprivation and location status. 
Practice Deprivation statusa Location 
A High Inner city
B High Inner city
C Moderate Urban
D Moderate Urban
E Low Semi-rural
aCategories defined according to low income scheme index 
prescribing data.
sample was prior parental experience of autistic disorders or
the mumps, measles or rubella diseases. Such experience
informed parents’ judgements of the acceptability of (a)
alternative outcomes, and (b) the perceived likelihood of a
given outcome.
Parents who declined vaccination in whole or part had
seen children with autism first-hand through family, friends
or work, or believed their own child to be autistic (though not
all cases were medically confirmed). These parents perceived
that the disabling long-term impact of the disorder was far
worse than the mumps, measles or rubella diseases. The
diseases were seen as relatively mild, treatable and natural
— something that the child would survive and even benefit
from:
‘I think there can be positive things about them catching
measles, mumps, and rubella. They’re not as serious as
the government makes out ... If children get measles,
mumps, and rubella it helps build up their natural immu-
nity, and that’s better than the immunity built up by
vaccines.’ (Practice E, parent 27e, first dose only.)
Conversely, those who agreed to immunise their child
were far more likely to have experienced, or observed in
relation to immediate family, the negative impact of the
measles, mumps or rubella diseases in terms of acute 
illness or long-term impairment:
‘We’d decided that whatever the risks were of having the
vaccination, of possible problems, we still felt it was just
better for them to have the injections than run the risk of
any of the diseases. My husband is deaf in one ear and
that happened, they’re almost certain, after he had the
measles as a child and so he felt it was far more important
that they did [get vaccinated] and run a very small risk of
autism.’ (Practice C, parent 10c, complete vaccinator.)
‘Measles, mumps, and rubella inoculation is very impor-
tant to me. My husband had a brother who died when he
was 1 year of age with measles encephalitis and I think
one of the big problems with parents — because I’ve
talked to people quite a lot about it — is that they don’t
realise how serious measles is and can be as a disease.’
(Practice C, parent 12c, complete vaccinator.)
For reluctant vaccinators, who agreed to a second dose of
MMR vaccine despite strong reservations, their decision was
based on assessment of outcome likelihood rather than
impact. Two factors encouraged assessments indicating low
autism risk. First, their child did not have any problems after
the first dose. Second, parents observed no evidence 
of autistic disorder in their immediate social sphere. This 
second basis for risk assessment served for some as their
primary source of tangible facts:
‘The final thing that clinched it was just [name of partner]
and his like, sensible everyday comment, not rooted in
medical history that “Well do we know anybody who’s
had an adverse reaction?” Because that is rooted in
fact. Tangible fact that we can both hold on to. It’s not a
scientific report that we can’t understand, it’s actual
everyday living, and the answer to that was no. And
that’s why, that was the point that really made me realise
we were definitely going to go ahead [and vaccinate].’
(Practice C, parent 9c, complete vaccinator.)
For almost all parents, assessment of disease impact
and risk tended to have their basis in experiential knowl-
edge. Vaccination decisions were based on day-to-day
observation rather than the evidence of science. There
were exceptions, however. Where parents, or those known
to them, were employed in medical or scientific fields, they
acted as informal experts capable of weighing the evi-
dence and informing decision. Even here, though, some
parents felt a need to apologise for making a rational rather
than emotional response to the controversy that surround-
ed MMR, with one parent commenting that at some level it
‘sounds awful’ to be reliant on scientific information, the
implication being that as a mother she should just know
what is best.
Practitioner influence and limits
Beyond individual experience there were a range of factors
that served to confirm, complicate and occasionally alter
vaccination decision. The mass media raised concern and
initiated information search. Friends and family provided a
chance to share feelings and experience. GPs and health vis-
itors provided medical input, and were most frequently cited
as the best or most trusted source of information on MMR:
‘The GP was very good. Very good, very clear in her
advice. But not dictatorial. She just sort of presented me
with the facts and with the information ... I was able then
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Figure 1. Vaccination status for study sample. 
aIncomplete immuniser group can be subdivided further into
those who declined a second vaccination of MMR and those
waiting to be invited and intending to vaccinate. Split = 50/50.
Immunisers Non-immunisers
Complete Incomplete
Immunise at 
first dose
Immunise at 
first dose
Do not 
immunise at 
second dose
n = 12 (18%)a
Do not 
immunise at 
first dose
Do not 
immunise at 
second dose
n = 5 (7%)
Immunise at 
second dose
n = 52 (75%)
to come away and think, “Yes”. I felt at the time that it 
was the best advice.’ (Practice E, parent 29e, complete 
vaccinator.)
‘I’m very impressed with our GP, I think she’s very good
and I mostly see her for the children and she’s very good
with them.’ (Practice C, parent 27c, first dose, awaiting
second.)
‘Well, you have to put your trust in doctors.’ (Practice B,
parent 7b, complete vaccinator.)
Despite the trust most parents espoused in their local prac-
titioners, few cited them as decision influences. Although
often reluctant to criticise their individual GP or health visitor,
parents (particularly non-vaccinators) censured practitioners
en masse for being too willing to toe the party line on MMR,
being brain-washed by government and inevitably biased in
favour of vaccination by the award of target payments:
‘I've never had a problem with doctors not being willing
to listen to my viewpoint, but I know that doctors and
health professionals have to give the government line, so
I am not expecting an unbiased discussion.’ (Practice E,
parent 1, non-vaccinator.)
‘My problem with the advice coming from the GP is that
I know that GP practices are paid a bonus for having so
many patients vaccinated, so how can their advice be
impartial? They are running a business at the end of the
day.’ (Practice E, parent 12, non-vaccinator.)
Parents were also reluctant to initiate discussion during
consultation because of the rushed nature of general prac-
tice and the pressure of knowing there were other mothers
queuing in the waiting room. This pressure was felt by par-
ents and practitioners alike:
‘You’re conscious that there’s a waiting room outside of
children coming in to have the same injection and ... so
you know that there’s pressure on, don’t you? I suppose
you’re at the doctor’s surgery ... you’re [feeling] a bit
alien anyway. You just want to be in and out and you
don’t want to be causing a nuisance.’ (Practice E, parent
20e, first dose only.)
‘I’m conscious that the waiting room, the clinic at [name
of practice] is a 1 hour drop-in and you have all the world
sitting there. The pressure of people will make a differ-
ence.’ (Practice D, practitioner 3.)
Effectiveness of consultation was further diminished
where practitioners were felt to be unwilling to engage in
discussion of concerns, or were dismissive, condescending
or coercive. Consequently, although local practitioners were
identified as the most trusted information source in prin-
ciple, their actual role in decision support was hampered by
questions over partiality and concerns as to acceptability or
legitimacy of discussion during consultation.
Immediate support needs
Reliance on everyday knowledge coupled with insufficient
contact with primary care providers served to ensure that,
for a majority of parents, the decision on whether to vac-
cinate did not reflect an informed choice. Most parents
received no information prior to appointment for second
dose vaccination on the rationale, benefits and risks of
immunisation or the diseases, and could not recall advice
given at first dose 3 years previously. Where NHS leaflets
were available, they were perceived as dull and uninform-
ative when compared with the photographs and case hist-
ories employed by mass media. Official information was
felt to bear little relation to ‘real’ lives, communicating little
about the impact of either immunisation or the diseases. It
failed to make the issue of MMR vaccination real in minds
of parents and failed to communicate the importance of the
issue as compared with other campaigns, such as those
run by the National Society for Prevention of Cruelty to
Children (NSPCC):
‘I don’t think they’re [MMR leaflets] hard-hitting enough.
I know it’s not nice to see children on telly poorly and
what have you, but it’s like the ones for NSPCC, they
make you want to cry, but they make you understand
what’s going on and I think that’s what needs to be
done about MMR. I think a lot more information of how
many children have died in the past is what needs to be
published, so that people can see that it is working.
Otherwise there’s going to be a lot of poorly children
and a lot of dead, blind and deaf children about. You
know, when I was at college we was handed some fig-
ures of — I think it might have been 1970 or something
— of how many had died that year, how many were
blind and how many was deaf, compared to 2000. And
there was a dramatic difference and it was because of
all the immunisation. So I think probably they could do
with using that a bit more ... to prove to them [parents]
that it [immunisation] is working.’ (Practice D, parent
5d, complete vaccinator.)
Parents identified a number of factors likely to support
informed decision on MMR vaccination. Drop-in sessions and
forums at local nurseries or schools, dedicated to answering
parental concerns, would offer the chance to discuss health
controversies without the time constraints imposed within a
practice. There was a need for written information in the days
prior to a vaccination appointment, replete with case studies
and pictures so that parents could relate to and reflect on
available evidence. At the vaccination appointment, pract-
itioners should offer information and seek to elicit information
as a matter of course. This point was seen as necessary 
to overcome a tendency among practitioners (illustrated
below) to take presentation at clinic as indication of informed 
consent, while avoiding discussion of MMR and related
issues for fear of the concern that it may cause:
‘... you must be happy to have it done if you’ve brought
your child in, because if you did not want it you wouldn’t
bring them ... [we] don’t want to put doubts in their mind.
Because if there is any doubt in a parent’s mind they’re
going to say no ... if you keep going on more maybe
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you’re going to scare them more and they’ll say no then.’
(Practice D, practitioner 1.)
In terms of enhancing trust in any information provided,
parents highlighted a need to remove target payments, for
direction to other information sources, and for facilitated
access to independent third parties who could be trusted
to provide balanced accounts of the controversy and
underlying science. As revealed in the interview extract
below, parents wanted to be able to square feelings of trust
in their local GP with wider concerns over partiality and a
desire for independent decision support:
‘... I’m not aware of any independent place where they
could go and get independent advice. I don’t know
whether such a person exists ... I mean, I trust my GP,
some people don’t trust their GP. I think GPs sometimes
are seen to have hidden agendas about getting the
immunisation rates up ... they get to a certain target,
they get more benefits and things like that. Maybe other
parents aren’t aware of that and necessarily won’t take
that on board. But yes, somewhere where I could go
and get independent advice and maybe somewhere
that, where I could go and sit and talk about whether
they should have it [MMR vaccine] at 4 and 5 [years].
Not necessarily my GP, but somebody that, you know,
can listen and advise and I can take that information
away and then come to an informed decision.’ (Practice
B, parent 1, first dose only.)
Parents suggested that access to such information inter-
mediaries could be incorporated into the nursery or school
forums described above. This would provide an opportunity
to compare the views of local practitioners and third parties,
and offer parents a chance to discuss among themselves
how the information provided related to existing attitudes
and prevailing controversy. Finally, any information provided
in general practice, clinics or more novel settings should
seek to relate the risks and benefits of the intervention to the
parent’s local circumstances and individual child. This last
point was essential if educational attempts were to be
accepted as valid, meaningful and real.
Discussion
Summary of main findings in relation to existing 
literature
In line with existing literature, the research suggests that
parents and practitioners believe that primary care
providers ought to be an important source of vaccination
information.6,9-15 However, the suggestion that providing
more medical information will, in itself, increase parent
understanding is not supported. Such an assumption has
its basis in a cognitive deficit model of public understand-
ing that fails to account for the fact that the use to which
information is put is contingent on the social and instit-
utional connections associated with the information source;
trust in the message sender,23,24 and the ease with which
the information can be incorporated into existing know-
ledge and applied to the issue at hand.16
The research presented here indicates that the vaccin-
ation message is failing to get through, not because it is not
being said often enough or clearly enough (although this is
an issue at second dose), but because the information pro-
vided is not being integrated into parents’ pre-existing
experience and understanding. In concert with the work of
Layton and colleagues on the public understanding of 
science,16 this study indicates that there is limited utility in
providing more and better information on MMR vaccine risk
and disease impact unless that information is reworked and
translated to a point where it has relevance for each parent
within the context of their individual situation and particular
level of understanding. It must take account of the ‘tangible
facts’ (parent 9c, complete vaccinator) observed by people
in their own communities, and be presented in such a way
as to inform and transform the experiential information 
parents bring to consultation.
Strengths and limitations of this study
The qualitative methodology employed enabled an in-depth
exploration of parent and practitioner perspectives on infor-
mation and decision support as it relates to MMR vaccine,
paying particular attention to responder definitions and inter-
pretations. Despite drawing participants from a single health
region, the study succeeded in recruiting a broad range of
parents, differentiated according to age, family structure and
educational attainment across five practices. In complying
with the Data Protection Act (1998) and individual practice
concerns, details of non-responders were not collected. It is
not therefore possible to assess the impact that decisions
not to participate may have had on study findings. The
breakdown of participants by vaccination decision does,
however, reflect the national picture,20 which, when coupled
with the fact that interviews pertain to a widely used two-
dose vaccination schedule, ensures that findings can be
generalised to similar individuals and settings on contextual
and theoretical grounds.25
Implications for clinical practice and future
research
For health services to play a greater role in facilitating
informed decision there is a need to re-organise provision
to ensure more timely and engaging information transfer.
Simply providing more leaflets, television campaigns and
didactic verbal statements, in which medical evidence on
the effectiveness and safety of the vaccine is meant to flow
from the producers to consumers, is to fail to recognise the
need to contextualise information with ‘situation-specific
knowledge, often personal to individuals’.16 Parents need
to be seen as partners in a learning enterprise, rather than
passive receptors or empty cognitive vessels waiting to be
filled. Considered thus, the challenge becomes one of
managing information exchanges so as to collaboratively
transform, rather than coercively supplant, existing parent
knowledge.
The solution identified by parents in this study is the 
creation of multi-agency forums where the views of pract-
itioners, other parents and third parties are sought. Forums
situated in nurseries or schools could serve as community
524 British Journal of General Practice, July 2004
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health information shops offering parents an opportunity to
engage with primary care, health promotion, and scientific
and social academic accounts of the MMR controversy.
They would offer an opportunity to discuss different 
perspectives, embedding medical evidence within local 
contexts and individual learning accounts. This is not simply
an issue of offering more. Rather, it is about the nature of
information exchange and delivery. It is about delivering
information through trusted sources, in time-rich contexts
that enable parents to construct their own understanding,
aligned with medical evidence of best practice.
In calling for the provision of multi-agency fora, parents
confirm that there is growing concern over the ability of
practitioners to act as impartial guides. Questions about
financial incentives, government bias, restrictions on time,
training needs, lack of resources, and competing claims on
practitioner expertise26 threaten practitioner identity as a
trusted source.
At a national level, removal of target payments for vaccina-
tion may go some way to recovering practitioners’ position
as neutral guide.23 Even so, support at a local level is likely
to be required if parents are to fully trust and understand the
information supplied.
Parents must believe that practitioners are able to provide
balanced information, describing the risks and benefits of
vaccination and diseases. Embedding medical information
within existing experience requires that practitioners have
the time to ask parents what they already know, and ascer-
tain how best to link medical evidence to individual concerns
and understanding. Information provision should, as in the
best of existing practice, form part of a discussion in which
practitioners are able to relate medical research to individual
parents, children and communities, using visual imagery
and case studies to provide vicarious experience of the
impact of largely forgotten diseases. Practitioners then
emerge as a neutral expert source, capable of guiding par-
ents through conflicting evidence as part of a facilitated
learning process directed at informed choice. They emerge
as trusted partners in the interpretation of risk information,
capable of linking data to parents’ existing frames of refer-
ence and helping to transform schemata of reality.
GPs, health visitors and practice nurses are well placed to
facilitate medically informed decisions by parents and
patients only where there is trust in their impartiality. Such
trust is central to the facilitation of medically informed dec-
ision making and learning in the face of safety concerns and
healthcare crises — it is central to attempts to transform
existing understanding through the tailored embedding of
new knowledge. This is the case whether the issue is MMR,
hormone replacement therapy, or HIV/AIDs, be it in the UK
or other countries.
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